CE suggestion: The Optics of Free-Form Progressive Lenses

Article

Donna Suter suggests a Carl Zeiss Vision-supported continuing education (CE) program on free-form technology in progressive lenses.

Thanks to a suggestion from Donna Suter, Optometry Times-published president of Suter Consulting Group, we would like to point you to a continuing education program on new lens technology. The resource, from 2020Mag.com, is titled "The Optics of Free-Form Progressive Lenses."

The course, approved for one hour of CE credit by the American Board of Opticianry, is aimed at defining free-form technology in progressive lenses, demonstrating the benefits of using a computer engine to optimize prescriptions for these designs, and describing future use opportunities. The faculty/editorial board of the program includes Darryl J. Meister, ABOM, technical marketing manager for Carl Zeiss Vision.

When readers are finally finished with the program, it offers a test on the information. Test questions can even be viewed prior to taking the test. Those interested should take a look at the program as soon as possible, it will expire in a few months (November 30, 2012).

Again, thanks to Donna Suter for the suggestion. Check out the Suter Consulting Group on Facebook and a list of Donna Suter's published articles on Optometry Times.


Related Articles

Advances in free-form lens technology (and what they promise for you)

Offer patients the best lens for optimal vision

Sunwear au courant? The lenses have it

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.